These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1271942)
21. [Blood lipids in relation to age]. Rubio MJ; Tolosa-Latour M; Bellod P; Mariño M; de Oya M An Med Interna; 1988 Sep; 5(9):435-8. PubMed ID: 2856621 [No Abstract] [Full Text] [Related]
26. Evaluation of rapid screening methods for the detection of abnormal lipid states related to atherosclerosis. Boyle E; Dash HH; Owen D; Yarmosh D Ann Clin Lab Sci (1971); 1972; 2(5):393-403. PubMed ID: 4343280 [No Abstract] [Full Text] [Related]
27. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia]. Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562 [No Abstract] [Full Text] [Related]
28. [Epidemiology of hyperlipidemia in Austria]. Schwarz B; Kunze M Wien Med Wochenschr; 1994; 144(12-13):290-2. PubMed ID: 8650931 [TBL] [Abstract][Full Text] [Related]
29. [Blood cholesterol levels of 1263 healthy children]. Zhang QZ Zhonghua Yi Xue Za Zhi; 1986 Feb; 66(2):75-7, 124. PubMed ID: 3094854 [No Abstract] [Full Text] [Related]
31. [Heart infarction--pathogenesis, prognosis and therapy]. Werkö L Lakartidningen; 1974 Apr; 71(17):1723-31. PubMed ID: 4825279 [No Abstract] [Full Text] [Related]
32. Rationale for use of lipid-lowering drugs. Dayton S Fed Proc; 1971; 30(3):849-56. PubMed ID: 5575297 [No Abstract] [Full Text] [Related]
33. Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994. Rafiei M; Boshtam M; Sarraf-Zadegan N East Mediterr Health J; 1999 Jul; 5(4):766-77. PubMed ID: 11338699 [TBL] [Abstract][Full Text] [Related]
34. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. The Women's Health in the Lund Area (WHILA) study. Nerbrand C; Lidfeldt J; Nyberg P; Scherstén B; Samsioe G Maturitas; 2004 Jun; 48(2):161-9. PubMed ID: 15172091 [TBL] [Abstract][Full Text] [Related]
35. [Methods for primary screening and laboratory diagnosis of dyslipidemia. January 2000 Guidelines. Agence Nationale D'accréditation Et D'évaluation En Santé]. Agence Nationale D'accréditation Et D'évaluation En Santé (ANAES) J Mal Vasc; 2002 Oct; 27(4):226-30. PubMed ID: 12457129 [No Abstract] [Full Text] [Related]
36. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia]. Yeshurun D; Hamood H; Morad N; Naschitz J Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of hyperlipidemia in a large sample population. Bates HM J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S196-200. PubMed ID: 6177956 [TBL] [Abstract][Full Text] [Related]
38. [Physical training. 8. Possible therapy for hyperlipidemia and in preventive geriatrics?]. Carlson LA; Fröberg SO Lakartidningen; 1970 Oct; 67(41):4688-93. PubMed ID: 5482439 [No Abstract] [Full Text] [Related]
40. [Plasma lipids among the male population of different age groups]. Aleksandrow D; Michajlik A; Bartinikowska E Kardiol Pol; 1980; 23(2):111-7. PubMed ID: 7382258 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]